Insecticidal crystal proteins, or protoxins, of Bacillus thuringiensis are composed of two domains, an amino-terminal half essential for toxicity, and a carboxy-terminal half with an as yet unassigned function. To define the boundary of the two domains, sequential termination codons were introduced from the 3'-end of the DNA sequence encoding the toxic domain of the 1155-residue crylA(b) gene product. The mutated and the intact genes were placed under the control of the Escherichia coli inducible promoter PrecA, and toxicity of the cell extracts was determined using silkworm larvae. Under non-induced conditions, in which the gene products accumulated to a limited degree, mutations encoding 606 amino acid residues or more were toxic, whereas those encoding 605 residues or less were non-toxic. Comparison of the toxicities and the levels of the toxic proteins suggested that the mutant proteins had comparable activity to that of the intact protoxin. Furthermore, the non-toxic protein seemed to be unstable in the extracts. T o investigate the roles of the non-toxic domain, the mutant proteins were overproduced in both E. coli and B. thuringiensis. The intact and the mutated genes carrying natural promoters were introduced into acrystalliferous B. thuringiensis. Upon induction of PrecA in Em coli, and upon sporulation in B. thuringiensis, there was a large accumulation of gene products which formed inclusion bodies. The inclusion bodies of the intact protoxin were active, whereas those of the mutant proteins were inactive. Inclusion bodies of the intact protein could be solubilized in alkali, whereas the mutant inclusion bodies were insoluble. Since solubilization under alkaline conditions in the insect midgut is considered to be the first step of toxic action, the non-toxic domain is required to direct the synthesis of inclusion bodies as an active soluble form.
INTRODUCTION
The Gram-positive bacterium Bacill~s thuringiensis produces proteinaceous crystalline inclusion bodies during sporulation.The inclusion bodies are composed of one or more crystal proteins (Cry proteins), also termed 6-endotoxins, of 27-140 kDa. The Cry proteins possess lethal toxicity to various insect larvae, and many B.
The EMBL accession number for the full-length nucleotide sequence reported in this paper is M13898.
tburingiensis subspecies display different toxicities and insect-host ranges (Bulla e t al., 1977 (Bulla e t al., , 1980 ; Aronson e t .
The Cry proteins are protoxins, which, upon ingestion by a susceptible insect, are solubilized under the alkaline conditions of the midgut, and converted to low molecular mass, active toxins by the action of the midgut protease. Finally, the activated toxin molecules interact with specific receptors located in the epithelium of the midgut (Luthy & Ebersold, 1981) . Thus, toxicity is influenced by several factors, for example, solubility of Cry proteins, protease a,ction, and properties of receptors, but it remains to be Toxic border of B. tbztringiensis protoxin determined how these factors are related to the structure of the Cry proteins.
Over 40 genes encoding Cry proteins have been isolated, and their D N A sequences have been determined. Based on their structural similarities and their insect-host specificities, the cr_y genes have been classified into four major groups : cryl, Lepidoptera-specific ; cr~yll, Lepidoptera-and Diptera-specific ; crylll, Coleoptera-specific ; and c y W , Diptera-specific genes (Hofte & Whiteley, 1989) .
Most cry1 and some c r y W gene products (130-140 kDa) consist of two functional domains. The amino-terminal domain is essential for toxicity, and roughly corresponds to the protease-activated toxin, whereas the carboxyterminal domain is not essential for toxicity (Adang et al., 1985; Hofte e t al., 1986; Wabiko e t al., 1986) . The toxic domain is further subdivided into unique and conserved sequences. The variable size of the unique regions determines the insect host range (Ge e t al., 1989 ; Schnepf et al., 1990 ; Widner & Whiteley, 1990) . Five highly conserved blocks were identified, and were dispersed in the toxic domain (Hofte & Whiteley, 1989) .
The cry gene isolated from B. tburingiensis subsp. berliner 1715 (Klier e t al., 1982) belongs to the Lepidopteraspecific cryl group, and is now termed the cr_ylA(b) gene. The gene encodes a 1 155-amino acid (aa) polypeptide, and deletion analysis indicated that a 612 aa amino-terminal polypeptide was toxic, whereas a 603 aa polypeptide was not (Wabiko et al., 1986) . Similar analysis showed that a 607 aa polypeptide was toxic, whereas a 599 aa polypeptide was not (Hofte etal., 1986) . These results indicate that the boundary that defines the toxic domain exists between 603 and 607 residues. It was later found that this boundary region is included in one of the five highly conserved blocks as noted above. Elimination of this region caused the resultant polypeptide to be highly susceptible to proteolytic degradation (Hofte et al., 1986) . Furthermore, Haider & Ellar (1989) proposed a model for intramolecular association of the boundary region with the amino-terminus of the crylA(b) gene product from B. tbzlringiensis subsp. aixawai IC-1; this association may be responsible for determining insect-host specificity (Haider & Ellar, 1989 ). These analyses demonstrate the importance of the toxic boundary region in determining structural integrity and toxicity.
The amino acid sequence of the carboxy-terminal region is highly conserved and rich in cysteine residues. Therefore, this domain is implicated in the biogenesis of crystal inclusion bodies by disulfide bond formation (Hofte & Whiteley, 1989) . However, a possible function for the carboxy-terminal domain in determining toxicity has not been demonstrated. To further understand the structurefunction relationships of these domains, we have precisely located, by deletion analysis, the boundary of the toxic domain. Moreover, the non-toxic domain, namely the carboxy-terminal half of the protein was found t o be required for the production of active inclusion bodies in both E. coli and B. tburingiensis.
METHODS
Strains, media, plasmids, and chemicals. E. coli strains JM83 [ara A(lac-pro) thi s t r A (48OdlacZ AM15)] (Vieira & Messing, 1982) , and CSR603 (recA 1 ztvrA6phr-1 thr leupro arg thz] (Sancar e t al., 1979) were grown at 37 "C in LB medium (Sambrook et al., 1989) or in synthetic M9 medium (Sambrook et al., 1989) with appropriate supplements. The non-crystal-forming B. thuringiensis strain HD1 c y B (Stahly e t al., 1978) , was grown at 29 O C in LB medium or in modified GYS sporulation medium (1 g sodium citrate, 1 g glucose, 0.2 g MgSO,, 0.05 g MnSO,. H,O, 2 g (NH,),SO,, 3.3 g K,HPO,, 0.08 g CaCl,, and 2 g yeast extract at pH 7.5 in 1 1). Antibiotics added to the media were ampicillin (Amp, 50 pg ml-'), tetracycline (Tet, 12.5 pg ml-') and chloramphenicol (Cam, 5 pg ml-').
Plasmids pUC13 and pUC19 (Yanisch-Perron et al., 1985) were used for DNA cloning and sequencing. Plasmid pKH502 is a derivative of pBR322 and carries the portable operator and promoter (PrecA) of the E. coli recA gene (Shirakawa e t al., 1984) . The transcriptional start site of PrecA is located 32 bp upstream of a unique BamHI site. Under normal uninduced growth conditions, transcription from PrecA is repressed to a limited degree by the action of the LexA-repressor of E. coli. Upon induction by inhibition of DNA synthesis, for example by nalidixic acid, the repressor is inactivated, leading to high-level transcription from PrecA (Little & Mount, 1982) . The shuttle vector pHV33 (Rapoport e t al., 1979) , derived from pC194 (Horinouchi & Weisblum, 1982) and pBR322, confers Amp' and Tet' on E. coli, and Cam' on B. thtlringiensis. The recombinant plasmid pC34 is composed of pUC13 vector with a 5.4 kb insert (CfoI fragment) isolated from B. thtlringiensis subsp. berliner 171 5 (Wabiko e t al., 1986) (Fig. la) . This insert contains the fulllength c y gene together with 1.3 kb upstream and 0.5 kb downstream of the coding sequence. The upstream region includes two natural promoters, BtI and BtII (at 70-90 bp upstream of the initiation codon), which are activated in B. thtlringiensis upon sporulation (Wong etal., 1983) . The 80-130 bp downstream of the termination codon contains the positive regulator for mRNA stabilization in bacteria (Wong & Chang, 1986) . Plasmid pC022 is a deletion derivative of pC34 and contains the DNA sequence encoding the toxic segment, extending from the intact 5'-end to nucleotide (nt) position 1838 at the 3'-end (Fig. la) . Nt 1838 is immediately followed by GGG, which is the residual SmaI site at the cloning junction. This clone (pC022) expresses a polypeptide of 612 aa residues with additional amino acids due to extended translation into the vector region.
Urografin and nalidixic acid were purchased from Schering and Wako, respectively. Tran 35S-label (37 TBq mmol-'), a mixture of ~-[~~S]methionine and ~-[~~S]cysteine, was purchased from ICN Biomedicals. Silkworms were purchased from Kanebo Silk-elegance or were kindly provided by Dr Shiojima of Yamagata Prefectural Silkworm Institute. Artificial diet for silkworms was obtained from Nihon-Nosanko. Deletion and site-directed mutagenesis. For deletion-mutagenesis from the 3'-end of the toxic boundary region, plasmid pC022 was first digested with EcoRI to release a 272 bp fragment extending from nt 1577 of the c y gene to the pUC13 EcoRI site located 11 bp downstream of nt 1838 (Fig. la) . The entire digest was then treated with exonuclease I11 and nuclease S1 to create sequential 10-150 bp deletions at 3-4 bp intervals. Deleted DNAs were then filled in using the Klenow fragment of DNA polymerase I (Sambrook et al., 1989) . The final products were ligated using T4 DNA ligase, to a synthetic BamHI linker with termination codons (TAA) at both ends (5'-TAAGGATCCTTA-3'). Thus, deletions whose endpoints correspond to the third base in the codons would give rise to translation-termination at the relevant codons. The DNA sample was then successively digested with BamHI and HindIII, and the fragments were separated by 5 % (w/v) PAGE. The deletion products generated from the 157 bp HindIII (nt 1692)lEcoRI (in pUC13) segment ( Fig. la) were electro-eluted and ligated to vector pUCl9 which had been digested with BamHI and HindIII. The deletion endpoint was determined by DNA sequence analysis according to the method of Sanger et al. (1977) using [ U -~~S I~A T P and Sequenase version 2 sequencing kit (USB).
To introduce termination codons by site-directed mutagenesis, we employed primed amplification of the mutations by PCR as described by Hemsley e t al. (1989) . Initially, as a template, we used the deletion clone pC1822, containing only a 130 bp insert extending from nt 1692 (HindIII) to nt 1822, obtained as described above (Fig. la, b) . We also employed another template, pC100, containing a 1 kb HindIII fragment (nt 1692-nt 2744) inserted at the HindIII site of pUC19 in an orientation in which the nt 2744 HindIII site was situated proximal to the SacI site of pUC19 ( Fig. la, b) . Both of these two clones contained the boundary region of the toxic domain. Forward primers (2, 3 and 4, Fig. lb ) contained mutational changes in the boundary region: a sequence complementary to the termination codon, immediately followed by a mixture of two alternating nucleotides at each of the two tandemly located positions. From the latter nucleotide mixture, four possible nucleotide sequence combinations were expected ; one combination is a termination codon, and another is a codon encoding the wild-type amino acid. In this manner, two mutants could be isolated: one has the normal amino acid followed by one termination codon, and the other possesses two termination codons in tandem. These forward primers direct DNA synthesis towards the 130-150 bp c y gene segments (Fig. la) . Reverse primer (primer 1) contains the SacI and EcoRI recognition sequences of the polylinker region of pUCl9 (Fig. lb) , and DNA synthesis extends to the vector region. A pair of forward and reverse primers directed amplification of the entire 3 kb plasmid consisting of the vector (pUC13 or pUC19) and the 130-150 bp DNA segment extending from the HindIII site (nt 1692) to the toxic boundary region. A 100 pl PCR reaction mixture contained 100 mM Tris/HCl, pH 8-3, 500 mM KC1, 2.5 mM MgCl,, 50 ng pC1822 (or pClOO), 0.6 pg primer 1, 1.2 pg primer 2, 3, or 4, 1.2 mM each dNTP, 100 pg gelatin ml-', and 2 units Taq polymerase (Kurabo). Amplification was accomplished by 25 cycles of 94 "C (1 min), 45 OC (1 min), and 72 O C (12 min). Subsequent end-filling, phosphorylation and self-ligation have been previously described (Hemsley et al. , 1989) . Transformation of JM83 with the final products was performed according to the method of Chung & Miller (1988) . Induced mutations were confirmed by DNA sequencing.
Construction of recombinant plasmids. The intact c y gene and its mutant derivatives were cloned into pKH502, under the control of the PrecA promoter, as follows. Plasmid pC34 632 containing the full-length gene was digested with NdeI, excising a 4 kb fragment including the entire coding sequence with 82 bp upstream and 250 bp downstream (Fig. la) . The fragment was filled in, ligated to BamHI linkers as above, and cloned into the BamHI site of pUC13, to obtain pEYl1. A 3.3 kb BamHI (nt -82)/PvuII (nt 3242) fragment of pEY 11, containing the major part of the coding region ( Fig. 1 a) was ligated to a BamHI/ NruI fragment of pKH502 (containing the Amp' gene) to generate pKEY7. In this construct, the transcriptional start point from PrecA is located 121 bp upstream of the c y gene initiation codon. The 3.9 kb SacI (nt 1346)lPvuII (in pKH502) fragment of pKEY7, containing the 5'-end region of the c v gene as well as the Amp' gene, was ligated to a 2.2 kb SacI (nt 1346)/filledin BamHI (blunt end) fragment of pEYl1, containing the 3'-end region of the cty gene. The final full-length cry gene clone, pKEYll7, contained the insert identical to a 4 kb NdeI fragment included in pC34 (Fig. 2a) .
The deletion clones in pUC vectors (Fig. lc) were digested with EcoRI (in pUC13 and pUC19), filled in, and then cut with HindIII (nt 1692). The 130-1 50 bp fragments containing various mutations were ligated to a 4 3 kb HindIII (nt 1692)/PvuII (nt 3344) fragment of pKEY 117, thus generating plasmids pKEY38 through pKEY9 (Figs lc, 2a) .
To obtain clones suitable for expression of the full-length c y gene in B. tburingiensis, the hybrid plasmid pHV33 was first digested with Hind111 to generate pC194 (2.7 kb) and pBR322 (4.4 kb). The pC194 fragment was filled in and ligated to pC34, which had been linearized with SmaI. The resulting co-integrate plasmid pCW342 can replicate in both E. coli and B. tburingiensis (Fig. 2b) . T o obtain mutated clones, pCW342 was cut with PstI (in pUC13), and then treated with nuclease Ba131 to produce 20-30 bp deletions which eliminated the HindIII site adjacent to the PstI site. The deleted DNA was blunt-ended and digested with HindIII, releasing the 8.3 kb fragment comprising the region upstream from nt 1692 (HindIII site) of the c y gene, pUC13, and pC194 vector (Fig. 2b) . This fragment was ligated to the 1.5 kb HindIIIlfilled-in PstI (in the Amp' gene in pKH502) fragment of the deletion clones, pKEY38, pKEY22 and pKEY15, generating pCW38, pCW22 and pCW15 respectively. The recombinant plasmids were introduced into B. thuringiensis HD1 cyB strain by electroporation as described by Schurter e t al. (1989) , and about 300 Cam' transformants were obtained per pg of plasmid DNA.
Preparation of E. coli cell extracts. E. coli JM83 strains harbouring the various plasmids with c g genes under the control of PrecA were grown in 150 ml LB liquid medium plus Amp at 37 OC. Cells were collected by centrifugation, washed once with 20 ml 10 mM EDTA (pH 8.0), resuspended in 2 ml 10 mM EDTA (pH 8-0), and disrupted by lysozyme treatment (1 mg ml-l) at 0 "C for 40 rnin followed by sonication (Branson sonifier, model 200, output 4,30 YO duty, 20 bursts) as described previously (Wabiko e t al., 1985) , except that the subsequent alkali treatment was omitted.
Immunoprecipitation. E. coli cell extracts were cleared by centrifugation (55 000 g for 20 min at 4 "C). PMSF was added to 1 mM and 800 p1 (about 20 mg protein) was mixed with 5 pl antibody solution which had been raised against B. tburingiensis subsp. kurstaki Cry protein. The mixture was incubated at 4 "C for 20 h with gentle rocking. Protein G-Agarose (10 pl) (Calbiochem) was added to the mixture containing the immune complexes, and further incubated at 4 "C for 1.5 h with rocking. Fig. l(a) . (b) Plasmid pCW342 is composed of a 5.4 kb berliner DNA fragment (thick solid line), a 2.7 kb pUC13 fragment (open line) and a 2.7 kb pC194 fragment (thin solid line). Hindlll sites in parentheses were eliminated during cloning. The shaded bar corresponds to a 1.5 kb PstllPvull segment derived from pKH502. The restriction map and nucleotide positions are as in Fig. 1 (a) . The arrow indicates the direction of transcription from the two closely located natural promoters of B. thuringiensis (Wong eta/., 1983) . and 0.14 M p-mercaptoethanol. The adsorbed proteins were released from the agarose by heating the suspension at 85 "C for 10 min, and centrifuged at 1OOOOg for 3 min at room temperature. The supernatant was saved and Western blotted. SDSPAGE and Western blotting. Proteins were separated by SDS-10% (w/v) PAGE as described by Laemmli (1970) . The proteins were stained with Coomassie Brilliant Blue and then subjected to densitometric tracings (Shimadzu, model CS-9000). Alternatively, the proteins were transferred electrophoretically from the gel onto nitrocellulose filters and Western blotted as described previously by Wabiko et al. (1985) . In some experiments. antieens were visualized bv enhanced chemiluminRadioactive labelling of the plasmid-encoded proteins (maxicell technique). E. coli CSR603, harbouring plasmids, was grown in M9 medium supplemented with 1 % (w/v) Casamino acid, 0.1 pg thiamin ml-', and Amp at 37 "C to OD,,, 0.5. Cells were irradiated with UV light at 50 J m-2 for 45 s unless otherwise indicated. After 15 min at room temperature, Dcycloserine was added to 150 pg ml-' and the cells were incubated for a further 16 h at 37 "C with shaking. The plasmidencoded proteins were radioactively labelled according to the method of Sancar etal. (1979) using "ran 35S-label. The proteins were separated by SDS-PAGE and fluorographed using 1 M sodium salicylate as an intensifying reagent (Chamberlain, 1979) . " escence (ECL, Amersham) according to the manufacturer's instructions. Proteins were dissolved in 0.015 % (w/v) sodium deoxycholate and measured by a modification of the Lowry method (Peterson, 1977) .
Partial purification of the inclusion bodies. E. coli cells carrying the various plasmids were grown in LB medium with Amp as above but to OD,,, 0.2. PrecA promoter activity was induced by addition of nalidixic acid to 40 pg ml-' and $ Full-length. $ The promoter PrecA was induced by addition of nalidixic acid to 40 pg ml-'.
incubation was continued for 20 h at 37 OC. Cells were collected and disrupted by lysozyme treatment and sonication as described above, and the extracts were centrifuged at 1200g for 5 min at room temperature. The precipitates were enriched with the inclusion bodies of the Cry proteins. B. thuringiensis HD1 c g B strains, harbouring the recombinant plasmids were plated onto GYS medium supplemented with Cam, and incubated at 30 "C for 3 d until lysis of mother cells occurred due to sporulation. Insoluble materials were collected by centrifugation at 10 000 g for 10 min, and washed once with distilled water, and then sonicated briefly and passed twice through a French press (8000 p.s.i./55-2 MPa) to ensure complete cell lysis. Inclusion bodies were separated from spores according to the two-phase system consisting of PEG and dextran sulfate as described by Goodman e t al.
(1 967). Inclusion bodies were further purified by the density gradient centrifugation method of Sharpe et al. (1975) with the following modification. Inclusion bodies in 1 ml water were dispersed by brief sonication, and centrifuged through an 11 ml 5&80% (v/v) Urografin gradient in water, using a TST41.14 rotor (Kontron) at 40000 g for 30 min at 5 "C.
Inclusion bodies migrated to about the middle of the gradient. Solubilization of inclusion bodies. Partially purified inclusion bodies were dissolved in water to 2-8 mg protein ml-', and 100 pl aliquots were adjusted to pH 11-9 with 1 M NaOH. The mixtures were shaken gently for 2.5 h at 25 O C and undissolved materials were collected by centrifugation at 13 000 g for 20 min
at 4 O C . The supernatants were neutralized by addition of 5 p1 2 M Tris/HCl (pH 8*3), and 100 p1 water was then added to the pellets, followed by brief sonication to disperse them. Insect bioassay. A 0.3 ml aliquot of approriately diluted cell extracts or inclusion bodies in water was uniformly distributed onto the artificial diet in a 25 cm2 x 0.5 cm plate. Ten secondinstar larvae of the silkworm, Bombyx mori, were placed onto each plate and maintained at 22 OC, and mortality was monitored after 8 d.
RESULTS

Generation of 3'-end deletion mutations
T o introduce sequential amino acid deletions in the toxic boundary region, indivdiual codons of the gene encoding the toxic segment were replaced by one or two tandem termination codons by two approaches. First, deletions were generated from the 3'-end of the toxic clone pC022, and the endpoints were ligated to the termination codon TAA. The DNA sequences of the two mutant clones, pC1838 and pC1822, containing up to nt 1838 and nt 1822 of the cry gene, respectively, are presented in Fig. l(c) . The pC1838 clone contained an additional guanosine residue following nt 1838, which was derived from the residual SmaI cleavage site of pUC13 during deletion construction (Fig. la) . The resulting codon, GCG (C is at nt 1838), thus encodes alanine as in the wild-type protein (residue 613), where it is encoded by GCA (Fig. lc) . Since the codon GCG was directly linked to a termination codon TAA, the polypeptide terminates at residue 613 (Fig. lc) . In contrast, in the clone pC1822 the deletion endpoint (nt 1822) corresponded to the first base of the codon encoding residue 608, and ligation of nt 1822 to TAA caused frameshift to occur at residue 608. Consequently, extra amino acid residues were fused to the 607 aa polypeptide, such as in the clone pKEY22 (see below). The second procedure employed PCR using paired primers, one of which contained mutational changes (Fig.  1 b) . Two tandem termination codons were generated after residues 603 (pC1809), 605 (pC1815) and 606 (pC181 8), and one termination codon was introduced in these samples, one-tenth of the UV dose was employed. Cells were radiolabelled with ~-[~~S]methionine/cysteine, and the proteins were separated by SDS-10% PAGE followed by fluorography and exposed for 3 d at -80°C. Lanes: 1, pKEY117; 2 and 6, pKH502; 3, pKEY21; 4, pKEY18; 5, pKEY15. Positions of the mutant proteins are indicated by arrowheads.
after residues 604 (pC1812) or 607 (pC1821) (Fig. lc) ; these serial termination codons conferred sequential single-amino-acid deletions (Fig. lc) .
Toxicity of the deletion mutants
Mutated DNA segments (Fig. lc) as well as the full-length CTJJ gene were further cloned into the plasmid pKH502 to be controlled under the inducible E. coli, promoter PrecA (Figs lc, 2a) . In particular, the pKEY22 clone encodes a 607 aa polypeptide with an additional 10 aa residues due to extended translation beyond the deletion endpoint, and hereafter named the 607 + 10 aa clone. E. coli cells harbouring individual clones were grown under normal uninduced conditions, and the cell extracts were prepared and assayed for toxicity using silkworm larvae. Toxicity was determined, and expressed as the amount of total protein in the extracts required to give 50% insect mortality (LD50) ( Table 1 ). The full-length clone (pKEY117) showed the highest activity, while the 613 aa clone (pKEY38) was approximately 20-fold less active.
Both the 607 aa (pKEY21) and the 607 + 10 aa (pKEY22) clones possessed comparable toxicity to the 613 aa clone, indicating that elimination of residues between positions 613 and 608 did not affect insecticidal activity. With a further single-amino-acid deletion, generating the 606 aa clone (pKEY18), activity was reduced twofold in comparison with the 613 aa clone. Further deleted clones, 605 aa (pKEY 15), 604 aa (pKEY 12) and 603 aa (pKEY9), as well as the control vector (pKH502) displayed no lethal activity and caused no disease symptoms even though extracts were used at 150-fold higher levels than the LD50 of the full-length clone (Table 1 and unpublished results).
These results indicated that the border which discriminates the toxic from the non-toxic portion of the protein is located at residue 606.
T o identify the mutant proteins in the extracts, the proteins were enriched by immunoprecipitation and Western blotted. An intact 130 kDa protoxin antigen was clearly identified in the full-length clone pKEY 1 17 (Fig.  3a, lane l) , and distinct 65 kDa toxin polypeptides were found in the toxic clones, 613 aa (pKEY38), 607 aa (pKEY21) and 606 aa (pKEY18) (Fig. 3a, lanes 2-4) . In contrast, immunoreactive polypeptides were not evident in the non-toxic clone, 605 aa (pKEY15), or in the strain harbouring the vector pKH502 alone (Fig. 3a , lanes 5 and 6). Densitometric tracing of the immunologically stained protein bands indicated that the amount of full-length protein was 15-fold higher than the amount of mutated proteins. This difference presumably accounts for the difference in levels of the cry gene products in E. coli extracts, based on the result that the full-length and the truncated toxic proteins appeared to be equally immunoreactive to the antibody (see below). Therefore, it is suggested that the mutant proteins were accumulated to a lesser extent than the intact protein in E. d i cells or in cell extracts, Furthermore, this 15-fold difference in amounts correlated well with the finding that the extracts from the full-length clone possessed 20-fold higher toxicity than those from the mutant clones. These analyses suggest that toxicity of the mutant proteins on a molar basis is comparable to that of the intact protoxin in case of the 613 aa and 607 aa proteins, and about twofold less active in the case of the 606 aa protein.
To further investigate whether the non-toxic 605 aa clone produced the gene product, the plasmid-encoded protein were radioactively labelled in E. coli by the maxicell technique. A mutant protein of about 65 kDa was found in the non-toxic 605 aa clone, (Fig. 3b , lane 5) as well as in the toxic 607 aa and 606 aa clones (Fig. 3b, lanes 3 and 4) , although these proteins constitute only a minor fraction of the total labelled proteins. The corresponding protein was absent in the strain carrying the control vector pKH502 (Fig. 3b, lane 6) . Radiolabelling of the fulllength gene product was more susceptible to UV light than that of the deleted gene, presumably due to the longer DNA segment in the full-length gene (Fig. 3b , lane l), causing more damage by UV light. Consequently, we were unable to compare precise amounts of the mutant proteins with the intact protein in the labelled extracts. However, the possibility that the lack of toxicity in the 605 aa clone was due to the lack of synthesis of this particular protein in vivo can be excluded.
Effect of overproduction of intact and mutant Cry proteins in E. coli and B. thuringiensis
The mutant clones described above apparently lack the non-toxic carboxy-half domain. To study possible roles of this region in generating active molecules in vim, a large Immunological identification of full-length and mutated cry gene products in partially purified inclusion bodies. Partially purified inclusion bodies were separated by SDS-10% PAGE and Western blotted. Lanes: 1, pKEYll7; 2, pKEY38; 3, pKH502.
amount of the full-length and deleted Cry proteins was produced in both E. coli and in B. tburingiensis. The promoter PrecA was activated in E. coli carrying either the full-length clone (pKEY117) or the 613 aa clone (pKEY38). Phase-refractile inclusion bodies were observed within cells of both the clones, but not of the vector pKH502. Analysis of whole-cell extracts by gel electrophoresis revealed that proteins of 130 kDa and 65 kDa accumulated predominantly in the pKEY 1 17 and pKEY38 cultures, respectively (Fig. 4a, lanes 2 and 5) . The size of these proteins agreed well with those deduced from the DNA sequence. By densitometric tracing of the Coomassie Brilliant-Blue-stained gel, there was an estimated sevenfold increase in these proteins. The 130 kDa and 65 kDa proteins were enriched in the partially purified inclusion body fraction (Fig. 4a , lanes 3 and 6), and these reacted equally well with the antibody raised against the Cry protein (Fig. 4c, lanes 1 and 2) . In addition, several polypeptides smaller than the 130 kDa and 65 kDa proteins were copurified with the inclusion body fraction, and they were also immunoreactive with the antibody (Fig. 4c) . These proteins are likely to be the degradation products or premature termination products of the individual genes.
The LD,, of whole-cell extracts from the induced fulllength clone was reproducibly sevenfold lower than that of the non-induced extracts (Table 1) . This value agrees well with the increased level of the induced 130 kDa protoxin described above, and suggests that the molar specific toxicity of the intact Cry protein remained unchanged during inclusion body formation. In contrast, extracts prepared from the induced deletion clone, pKEY38, showed no toxicity even though 2.7-times the LD,, of the uninduced pKEY38 was used (Table 1 ). This result shows that the inclusion bodies of intrinsically active 613 aa polypeptide had lost toxic activity. T o determine if this also occurred in B. tburingiensis, cry genes under control of the natural promoters of B. tbtlringiensis were cloned into the shuttle vector to generate pCW342 (full-length), the mutated toxic clones pCW38 (613 aa) and pCW22 (607 + 10 aa), and the non-toxic clone pCW15
(605 aa) (Figs lc, 2b ). These recombinant plasmids were introduced into the non-crystal-forming B. tburingiensis HD1 cryB strain. Cells harbouring these plasmids were allowed to sporulate, and as expected, a high yield of cry gene products was achieved, which formed phase-refractile inclusion bodies. All of the cry gene products in partially purified inclusion bodies ( Fig. 5a lanes 1,4,7 and 10) reacted comparably with the antibody (Fig. 5b) .
Inclusions from the full-length clone were highly toxic, whereas toxicity of the mutant inclusion bodies was completely abolished (Table 1) . From these results, we concluded that the non-toxic portion was required to retain activity during inclusion body formation in both E. coli and B. tburingiensis. 
Solubility of the inclusion bodies
Since the 61 3 aa and 607 aa polypeptides were active when produced in limited amounts, we reasoned that inactivation of toxicity may have been due to the insensitivity of the inclusion bodies to external factors which normally activate the toxins. The first step of such activation is considered to be solubilization of the inclusion bodies under the alkaline conditions of the insect midgut. Partially purified inclusion bodies from both E. coli and B.
tbzlringiensis were treated with alkaline solution, and the solubilized proteins were separated from the insoluble materials by centrifugation. Analysis of these fractions by SDS-PAGE showed that the full-length Cry proteins were recovered in the supernatant fraction (Fig. 4b , lane 2; Fig. 5a , lane 2), whereas all the mutant proteins remained in the precipitates (Fig. 4b, lane 6; Fig. 5a , lanes 6, 9 and 12). This result clearly demonstrated that the mutant Cry proteins were defective in their capacity to be solubilized when they formed inclusion bodies.
DISCUSSION
To localize the toxic boundary of a B. tbzlringiensis protoxin, sequential termination codons were introduced from the 3'-end of the toxic gene segment of the cgdA(b) protoxin gene by in vitro mutagenesis. When the gene products were synthesized in limited amounts, mutations encoding 606 aa or more were toxic, whereas those encoding 605 aa or less were not. The critical residue, therefore, occurred at position 606. Close examination of toxicity of the extracts and the amount of proteins in the immunoprecipitates revealed that molar specific toxicity is comparable among the intact and the mutant proteins of 613 aa and 607 aa residues, and that the 606 aa protein was slightly less active than the intact protoxin, despite the fact that these mutant proteins were accumulated less than the wild-type protein. Low-level accumulation of the toxic proteins might be due to the instability of the proteins or premature termination of gene expression. Although the non-toxic 605 aa protein was not recovered in the immunoprecipitates, accumulation of the corresponding protein in E. coli was demonstrated in the radiolabelling experiments. The 605 aa protein could be even more unstable than the mutant toxic proteins, so that it was degraded rapidly during the subsequent process of immunoprecipitation. Alternatively, the protein may be equally as stable as the toxic mutant proteins, but had lost its antigenic determinant upon conformational change. The latter possibility seems to be unlikely, since the protein was clearly recognized by the antibody (Fig. 5b) when it was synthesized abundantly in B. tbtlringiensis. In any event, a critical residue, 606, plays an important role in determining the structural integrity of the toxic polypeptide. In agreement with our results, Hofte e t al.
(1986), using the same gene as that described here, observed that the non-toxic 599 aa clone produced less antigenic polypeptide than the toxic 607 aa polypeptide. Adang e t al. (1985) observed that a non-toxic 57 kDa truncated Cry protein from B. tbzlringiensis subsp. ktlrstaki HD-73 was not reactive with the monoclonal antibody.
The critical residue, 606, is included in block 5, which consists of 12 aa extending from residue 597 to residue 608 of the cryIA(6) gene product and one of the five conserved subdomains of the toxic portion (Hofte & Whiteley, 1989) . Furthermore, residue 606 (proline) is identical for 9 of the 10 cry gene sequences of different host-specificity (Hofte & Whiteley, 1989) . The importance of the boundary region has been suggested in several studies. The recrystallized structure of the Coleopteraspecific CryIIIA toxin from subsp. tenebrionis implies that the corresponding toxic boundary region interacts with the helical bundle to confer structural integrity on the toxin molecule (Li e t al., 1991) .
Elimination of the toxic boundary region equally affected the toxicity against several lepidopteran and dipteran insect hosts (this study and Adang et al., 1985; Hofte e t al., 1986; Wabiko e t al., 1986; Pao-Intara e t al., 1988) , suggesting that this region could be involved in a common pathway of toxic action, rather than host range determination. It remains to be determined how the difference in a single amino acid between the 606aa and 605 aa clones might affect structure of the toxin molecule, and if this difference also affects host specificity.
To elucidate possible roles of the non-toxic domain, we employed two experimental systems. First, as noted above, when they were synthesized to a limited degree the mutant proteins were apparently unstable or were poorly expressed compared to the full-length protoxin : this suggests either that the non-toxic domain may confer stability of the toxic domain in E. coli, presumably by mutual interaction between the two domains, or that DNA segments encoding the non-toxic domain may be responsible for full expression of the cry gene. Secondly, the mutated as well as the full-length genes were highly expressed in E. coli and B. thtlringiensis. In both species, inclusion bodies of the full-length clone were fully toxic, whereas those of the mutant clones had lost their toxicity, although the latter clones were intrinsically toxic. Since the 613 aa mutant contains in-frame termination codons, the possibility that inactivation was caused by the modified carboxy-terminal end can be excluded. Inclusion bodies of the mutant polypeptides were extremely insoluble in alkaline conditions that mimic the alkaline environment in the midgut of the target insects. In contrast, active full-length inclusion bodies were soluble under the same conditions. Since solubilization is considered to be the first step in the activation of toxic proteins in the crystals, insolubility presumably accounts for the loss of toxicity of the mutant protein inclusions. These results demonstrate that the non-toxic domain is required to direct the synthesis of active inclusion bodies.
The non-toxic domain may interact with the toxic domain, thereby preventing formation of tight aggregates consisting of the toxic domain. It is also possible that the nontoxic domain interacts with the putative chaperone proteins to promote correct folding of the intact protoxin, which is required to form alkali-soluble inclusion bodies.
Cysteine residues have been suggested to participate in crystal formation through disulfide bonds (Liithy & Ebersold, 1981) . Since most of the cystine residues (1 0 out of 12) are located in the carboxy-terminal domain, this region may be required for crystal formation. Nakamura e t al. (1990) showed that some chimeric c q genes containing non-toxic segments from different gene sources are poorly soluble in alkali, suggesting that solubility of the artificial proteins is related to the combination of cysteine residues located in the individual segments. Our preliminary results indicate that deletion from the PvtlII site (nt 3242, Fig. la) to about 500 bp downstream of the 3'-end of the intact cry gene (clone pKEY7), also resulted in the alkali-insoluble inclusion body formation in E. coli (data not shown). Since this particular deletion polypeptide contains all the cysteine residues, these residues may not in themselves be sufficient to generate alkali-soluble crystalline inclusions. These results suggest that not only cysteine residues but also the overall structural integrity of the non-toxic domain plays an important role in the synthesis of active inclusion bodies. The importance of solubility is well documented ; for example, Aronson e t al.
( 1 991) showed that differential solubility of the native crystal from B. thtlringiensis subsp. a i p~a i HD133 is related to toxic activity.
Since the amino acid sequence of the non-toxic domain is highly conserved for all cry1 and c r y W gene products, the requirement of this domain in producing active inclusion bodies could be a general phenomenon in the other crystals displaying a variety of insect-host specificities.
